International Journal of Diabetes Research
p-ISSN: 2163-1638 e-ISSN: 2163-1646
2017; 6(2): 41-46
doi:10.5923/j.diabetes.20170602.02
Khalid Mohammad Mahmoud Mohany1, 2, Mohamad Yosof Rezk3, Hany Ahmed Elkatawy3
1Basic Medical Science, Unaizah Collage of Medicine (UCM), Qassim University, Saudi Arabia
2Medical Biochemistry Department, Faculty of Medicine, Assiut University, Egypt
3Medical Physiology Department, Faculty of Medicine, Zagazig University, Egypt
Correspondence to: Mohamad Yosof Rezk, Medical Physiology Department, Faculty of Medicine, Zagazig University, Egypt.
Email: |
Copyright © 2017 Scientific & Academic Publishing. All Rights Reserved.
This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/
Background: diabetic nephropathy (DN) is a major cause of end-stage renal disease. The current study tested the circulating miR-155 levels and their correlation with serum neutrophil-gelatinase associated lipocalin (sNGAL), in normal persons and in patients with DN. Objectives: It aimed at finding a new biomarker for prediction DN to slowdown the loss of renal function. Subjects & Methods: this work is a case control study that included 48 participants, divided into: G1 [control, (n=10)] and G2, G3 and G4 [type 2 diabetic patients with normoalbuminuria (n=11), microalbuminuria (n=17), and macroalbuminuria (n=10), respectively]. Blood and urine samples were taken from all participants. Serum glucose, sNGAL, glycosylated hemoglobin percentage, urinary albumin were estimated by their specific kits, serum and urinary creatinine by alkaline picrate method and serum miR-155 values by RT-qPCR. Results: serum miR-155 and sNGAL levels differed significantly between groups (p=0.000), with high values observed in G4 followedby G3, G2 then G1. Significant high levels of miR-155 and sNGAL were found in G2 when compared to G1 (p= 0.013 and 0.0005 respectively). Serum miR-155 values correlated with sNGAL in G1 (r= 0.569, p= 0.009), G2 (r= 0.834, p= 0.000), G3 (r= 0.471, p= 0.004) and G4 (r= 0.596, p= 0.007). Conclusion: the miR-155 levels increase early in diabetic nephropathy even before the onset of microalbuminuria and these levels correlate with the sNGAL levels. Measurement of miR-155 levels could enhance the prediction of DN and improve its management protocol.
Keywords: Diabetic nephropathy (DN), miR-155, Serum neutrophil gelatinase associated lipocalin (sNGAL)
Cite this paper: Khalid Mohammad Mahmoud Mohany, Mohamad Yosof Rezk, Hany Ahmed Elkatawy, Circulating miR-155 Levels Correlate with Serum Neutrophil Gelatinase Associated Lipocalin in Patients with Diabetic Nephropathy, International Journal of Diabetes Research, Vol. 6 No. 2, 2017, pp. 41-46. doi: 10.5923/j.diabetes.20170602.02.
|
Figure (1). Correlation between miR-155 relative expression and serum neutrophil gelatinase associated lipocalin in various studied groups |